APO Research, Inc.

APO RESEARCH · REPORT

Drugs for Traveler's Diarrhea

Selected research

Industry Growth & Trends

Global Drugs for Traveler's Diarrhea Industry Growth and Trends Forecast to 2032

Market perspective

The global Drugs for Traveler's Diarrhea market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Drugs for Traveler's Diarrhea is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Drugs for Traveler's Diarrhea is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs for Traveler's Diarrhea is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drugs for Traveler's Diarrhea include GSK, Sigmoid Pharma, Scandinavian Biopharma, Salix Pharmaceuticals, Prokarium Limited, Nippon Shinyaku, Cosmo Pharmaceuticals and Chiesi Farmaceutici, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Drugs for Traveler's Diarrhea market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Drugs for Traveler's Diarrhea market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Drugs for Traveler's Diarrhea market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Drugs for Traveler's Diarrhea.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Drugs for Traveler's Diarrhea market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Drugs for Traveler's Diarrhea Market by Company

GSK

Sigmoid Pharma

Scandinavian Biopharma

Salix Pharmaceuticals

Prokarium Limited

Nippon Shinyaku

Cosmo Pharmaceuticals

Chiesi Farmaceutici

Drugs for Traveler's Diarrhea Segment by Type

Antibiotics

Anti-motility agents

Bismuth Subsalicylate (Pepto-Bismol)

Drugs for Traveler's Diarrhea Segment by Application

Adult

Children

Drugs for Traveler's Diarrhea Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Traveler's Diarrhea market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs for Traveler's Diarrhea and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Traveler's Diarrhea.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drugs for Traveler's Diarrhea manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Drugs for Traveler's Diarrhea in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antibiotics Table 2. Major Company of Anti-motility agents Table 3. Major Company of Bismuth Subsalicylate (Pepto-Bismol) Table 4. Global Drugs for Traveler's Diarrhea Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Drugs for Traveler's Diarrhea Sales by Type (2021-2026) & (W Units) Table 6. Global Drugs for Traveler's Diarrhea Sales Market Share in Volume by Type (2021-2026) Table 7. Global Drugs for Traveler's Diarrhea Sales by Type (2021-2026) & (US$ Million) Table 8. Global Drugs for Traveler's Diarrhea Sales Market Share in Value by Type (2021-2026) Table 9. Global Drugs for Traveler's Diarrhea Price by Type (2021-2026) & (US$/Unit) Table 10. Global Drugs for Traveler's Diarrhea Sales by Type (2027-2032) & (W Units) Table 11. Global Drugs for Traveler's Diarrhea Sales Market Share in Volume by Type (2027-2032) Table 12. Global Drugs for Traveler's Diarrhea Sales by Type (2027-2032) & (US$ Million) Table 13. Global Drugs for Traveler's Diarrhea Sales Market Share in Value by Type (2027-2032) Table 14. Global Drugs for Traveler's Diarrhea Price by Type (2027-2032) & (US$/Unit) Table 15. North America Drugs for Traveler's Diarrhea Sales by Type (2021-2026) & (W Units) Table 16. North America Drugs for Traveler's Diarrhea Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Drugs for Traveler's Diarrhea Sales by Type (2021-2026) & (W Units) Table 18. Europe Drugs for Traveler's Diarrhea Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Drugs for Traveler's Diarrhea Sales by Type (2021-2026) & (W Units) Table 20. Asia-Pacific Drugs for Traveler's Diarrhea Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Drugs for Traveler's Diarrhea Sales by Type (2021-2026) & (W Units) Table 22. Latin America Drugs for Traveler's Diarrhea Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Drugs for Traveler's Diarrhea Sales by Type (2021-2026) & (W Units) Table 24. Middle East and Africa Drugs for Traveler's Diarrhea Sales by Type (2021-2026) & (US$ Million) Table 25. Drugs for Traveler's Diarrhea Industry Trends Table 26. Drugs for Traveler's Diarrhea Industry Drivers Table 27. Drugs for Traveler's Diarrhea Industry Opportunities and Challenges Table 28. Drugs for Traveler's Diarrhea Industry Restraints Table 29. Global Drugs for Traveler's Diarrhea Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Drugs for Traveler's Diarrhea Revenue Market Share by Company (2021-2026) Table 31. Global Drugs for Traveler's Diarrhea Sales by Company (2021-2026) & (W Units) Table 32. Global Drugs for Traveler's Diarrhea Sales Share by Company (2021-2026) Table 33. Global Drugs for Traveler's Diarrhea Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Drugs for Traveler's Diarrhea Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Drugs for Traveler's Diarrhea Major Company Production Sites and Headquarters Table 36. Global Drugs for Traveler's Diarrhea Company, Product Type & Application Table 37. Global Drugs for Traveler's Diarrhea Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Drugs for Traveler's Diarrhea by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Drugs for Traveler's Diarrhea Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Drugs for Traveler's Diarrhea Sales by Region (2021-2026) & (W Units) Table 42. Global Drugs for Traveler's Diarrhea Sales Market Share in Volume by Region (2021-2026) Table 43. Global Drugs for Traveler's Diarrhea Sales by Region (2021-2026) & (US$ Million) Table 44. Global Drugs for Traveler's Diarrhea Sales Market Share in Value by Region (2021-2026) Table 45. Global Drugs for Traveler's Diarrhea Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Drugs for Traveler's Diarrhea Sales by Region (2027-2032) & (W Units) Table 47. Global Drugs for Traveler's Diarrhea Sales Market Share in Volume by Region (2027-2032) Table 48. Global Drugs for Traveler's Diarrhea Sales by Region (2027-2032) & (US$ Million) Table 49. Global Drugs for Traveler's Diarrhea Sales Market Share in Value by Region (2027-2032) Table 50. Global Drugs for Traveler's Diarrhea Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Drugs for Traveler's Diarrhea Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Drugs for Traveler's Diarrhea Sales by Application (2021-2026) & (W Units) Table 53. Global Drugs for Traveler's Diarrhea Sales Market Share in Volume by Application (2021-2026) Table 54. Global Drugs for Traveler's Diarrhea Sales by Application (2021-2026) & (US$ Million) Table 55. Global Drugs for Traveler's Diarrhea Sales Market Share in Value by Application (2021-2026) Table 56. Global Drugs for Traveler's Diarrhea Price by Application (2021-2026) & (US$/Unit) Table 57. Global Drugs for Traveler's Diarrhea Sales by Application (2027-2032) & (W Units) Table 58. Global Drugs for Traveler's Diarrhea Sales Market Share in Volume by Application (2027-2032) Table 59. Global Drugs for Traveler's Diarrhea Sales by Application (2027-2032) & (US$ Million) Table 60. Global Drugs for Traveler's Diarrhea Sales Market Share in Value by Application (2027-2032) Table 61. Global Drugs for Traveler's Diarrhea Price by Application (2027-2032) & (US$/Unit) Table 62. North America Drugs for Traveler's Diarrhea Sales by Application (2021-2026) & (W Units) Table 63. North America Drugs for Traveler's Diarrhea Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Drugs for Traveler's Diarrhea Sales by Application (2021-2026) & (W Units) Table 65. Europe Drugs for Traveler's Diarrhea Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Drugs for Traveler's Diarrhea Sales by Application (2021-2026) & (W Units) Table 67. Asia-Pacific Drugs for Traveler's Diarrhea Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Drugs for Traveler's Diarrhea Sales by Application (2021-2026) & (W Units) Table 69. Latin America Drugs for Traveler's Diarrhea Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Drugs for Traveler's Diarrhea Sales by Application (2021-2026) & (W Units) Table 71. Middle East and Africa Drugs for Traveler's Diarrhea Sales by Application (2021-2026) & (US$ Million) Table 72. GSK Company Information Table 73. GSK Business Overview Table 74. GSK Drugs for Traveler's Diarrhea Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. GSK Drugs for Traveler's Diarrhea Product Portfolio Table 76. GSK Recent Development Table 77. Sigmoid Pharma Company Information Table 78. Sigmoid Pharma Business Overview Table 79. Sigmoid Pharma Drugs for Traveler's Diarrhea Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sigmoid Pharma Drugs for Traveler's Diarrhea Product Portfolio Table 81. Sigmoid Pharma Recent Development Table 82. Scandinavian Biopharma Company Information Table 83. Scandinavian Biopharma Business Overview Table 84. Scandinavian Biopharma Drugs for Traveler's Diarrhea Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Scandinavian Biopharma Drugs for Traveler's Diarrhea Product Portfolio Table 86. Scandinavian Biopharma Recent Development Table 87. Salix Pharmaceuticals Company Information Table 88. Salix Pharmaceuticals Business Overview Table 89. Salix Pharmaceuticals Drugs for Traveler's Diarrhea Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Salix Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio Table 91. Salix Pharmaceuticals Recent Development Table 92. Prokarium Limited Company Information Table 93. Prokarium Limited Business Overview Table 94. Prokarium Limited Drugs for Traveler's Diarrhea Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Prokarium Limited Drugs for Traveler's Diarrhea Product Portfolio Table 96. Prokarium Limited Recent Development Table 97. Nippon Shinyaku Company Information Table 98. Nippon Shinyaku Business Overview Table 99. Nippon Shinyaku Drugs for Traveler's Diarrhea Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Nippon Shinyaku Drugs for Traveler's Diarrhea Product Portfolio Table 101. Nippon Shinyaku Recent Development Table 102. Cosmo Pharmaceuticals Company Information Table 103. Cosmo Pharmaceuticals Business Overview Table 104. Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio Table 106. Cosmo Pharmaceuticals Recent Development Table 107. Chiesi Farmaceutici Company Information Table 108. Chiesi Farmaceutici Business Overview Table 109. Chiesi Farmaceutici Drugs for Traveler's Diarrhea Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Chiesi Farmaceutici Drugs for Traveler's Diarrhea Product Portfolio Table 111. Chiesi Farmaceutici Recent Development Table 112. North America Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 113. North America Drugs for Traveler's Diarrhea Sales by Country (2021-2026) & (W Units) Table 114. North America Drugs for Traveler's Diarrhea Sales Market Share by Country (2021-2026) Table 115. North America Drugs for Traveler's Diarrhea Sales Forecast by Country (2027-2032) & (W Units) Table 116. North America Drugs for Traveler's Diarrhea Sales Market Share Forecast by Country (2027-2032) Table 117. North America Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Drugs for Traveler's Diarrhea Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Drugs for Traveler's Diarrhea Market Share by Country (2021-2026) Table 120. North America Drugs for Traveler's Diarrhea Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Drugs for Traveler's Diarrhea Market Share Forecast by Country (2027-2032) Table 122. Europe Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 123. Europe Drugs for Traveler's Diarrhea Sales by Country (2021-2026) & (W Units) Table 124. Europe Drugs for Traveler's Diarrhea Sales Market Share by Country (2021-2026) Table 125. Europe Drugs for Traveler's Diarrhea Sales Forecast by Country (2027-2032) & (W Units) Table 126. Europe Drugs for Traveler's Diarrhea Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Drugs for Traveler's Diarrhea Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Drugs for Traveler's Diarrhea Market Share by Country (2021-2026) Table 130. Europe Drugs for Traveler's Diarrhea Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Drugs for Traveler's Diarrhea Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Drugs for Traveler's Diarrhea Sales by Country (2021-2026) & (W Units) Table 134. Asia-Pacific Drugs for Traveler's Diarrhea Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Drugs for Traveler's Diarrhea Sales Forecast by Country (2027-2032) & (W Units) Table 136. Asia-Pacific Drugs for Traveler's Diarrhea Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Drugs for Traveler's Diarrhea Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Drugs for Traveler's Diarrhea Market Share by Country (2021-2026) Table 140. Asia-Pacific Drugs for Traveler's Diarrhea Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Drugs for Traveler's Diarrhea Market Share Forecast by Country (2027-2032) Table 142. Latin America Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 143. Latin America Drugs for Traveler's Diarrhea Sales by Country (2021-2026) & (W Units) Table 144. Latin America Drugs for Traveler's Diarrhea Sales Market Share by Country (2021-2026) Table 145. Latin America Drugs for Traveler's Diarrhea Sales Forecast by Country (2027-2032) & (W Units) Table 146. Latin America Drugs for Traveler's Diarrhea Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Drugs for Traveler's Diarrhea Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Drugs for Traveler's Diarrhea Market Share by Country (2021-2026) Table 150. Latin America Drugs for Traveler's Diarrhea Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Drugs for Traveler's Diarrhea Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Drugs for Traveler's Diarrhea Sales by Country (2021-2026) & (W Units) Table 154. Middle East and Africa Drugs for Traveler's Diarrhea Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Drugs for Traveler's Diarrhea Sales Forecast by Country (2027-2032) & (W Units) Table 156. Middle East and Africa Drugs for Traveler's Diarrhea Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Drugs for Traveler's Diarrhea Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Drugs for Traveler's Diarrhea Market Share by Country (2021-2026) Table 160. Middle East and Africa Drugs for Traveler's Diarrhea Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Drugs for Traveler's Diarrhea Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Drugs for Traveler's Diarrhea Distributors List Table 165. Drugs for Traveler's Diarrhea Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Drugs for Traveler's Diarrhea Image Figure 2. Global Drugs for Traveler's Diarrhea Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs for Traveler's Diarrhea Market Size (2021-2032) & (US$ Million) Figure 4. Global Drugs for Traveler's Diarrhea Sales (2021-2032) & (W Units) Figure 5. Antibiotics Image Figure 6. Global Antibiotics Sales YoY Growth (2021-2032) & (W Units) Figure 7. Anti-motility agents Image Figure 8. Global Anti-motility agents Sales YoY Growth (2021-2032) & (W Units) Figure 9. Bismuth Subsalicylate (Pepto-Bismol) Image Figure 10. Global Bismuth Subsalicylate (Pepto-Bismol) Sales YoY Growth (2021-2032) & (W Units) Figure 11. Global Drugs for Traveler's Diarrhea Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Drugs for Traveler's Diarrhea Market Share by Type 2025 VS 2032 Figure 13. North America Drugs for Traveler's Diarrhea Sales Market Share in Volume by Type in 2025 Figure 14. North America Drugs for Traveler's Diarrhea Sales Market Share in Value by Type in 2025 Figure 15. Europe Drugs for Traveler's Diarrhea Sales Market Share in Volume by Type in 2025 Figure 16. Europe Drugs for Traveler's Diarrhea Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Drugs for Traveler's Diarrhea Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Drugs for Traveler's Diarrhea Sales Market Share in Value by Type in 2025 Figure 19. Latin America Drugs for Traveler's Diarrhea Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Drugs for Traveler's Diarrhea Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Drugs for Traveler's Diarrhea Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Drugs for Traveler's Diarrhea Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Drugs for Traveler's Diarrhea Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Adult Image Figure 26. Global Adult Sales YoY Growth (2021-2032) & (W Units) Figure 27. Children Image Figure 28. Global Children Sales YoY Growth (2021-2032) & (W Units) Figure 29. Global Drugs for Traveler's Diarrhea Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Drugs for Traveler's Diarrhea Market Share by Application 2025 VS 2032 Figure 31. North America Drugs for Traveler's Diarrhea Sales Market Share in Volume by Application in 2025 Figure 32. North America Drugs for Traveler's Diarrhea Sales Market Share in Value by Application in 2025 Figure 33. Europe Drugs for Traveler's Diarrhea Sales Market Share in Volume by Application in 2025 Figure 34. Europe Drugs for Traveler's Diarrhea Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Drugs for Traveler's Diarrhea Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Drugs for Traveler's Diarrhea Sales Market Share in Value by Application in 2025 Figure 37. Latin America Drugs for Traveler's Diarrhea Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Drugs for Traveler's Diarrhea Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Drugs for Traveler's Diarrhea Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Drugs for Traveler's Diarrhea Sales Market Share in Value by Application in 2025 Figure 41. North America Drugs for Traveler's Diarrhea Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 42. North America Drugs for Traveler's Diarrhea Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Drugs for Traveler's Diarrhea Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Drugs for Traveler's Diarrhea Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Drugs for Traveler's Diarrhea Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 46. Europe Drugs for Traveler's Diarrhea Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Drugs for Traveler's Diarrhea Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Drugs for Traveler's Diarrhea Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Drugs for Traveler's Diarrhea Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 50. Asia-Pacific Drugs for Traveler's Diarrhea Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Drugs for Traveler's Diarrhea Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Drugs for Traveler's Diarrhea Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Drugs for Traveler's Diarrhea Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 54. Latin America Drugs for Traveler's Diarrhea Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Drugs for Traveler's Diarrhea Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Drugs for Traveler's Diarrhea Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Drugs for Traveler's Diarrhea Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 58. Middle East and Africa Drugs for Traveler's Diarrhea Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Drugs for Traveler's Diarrhea Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Drugs for Traveler's Diarrhea Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Drugs for Traveler's Diarrhea Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Drugs for Traveler's Diarrhea Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Antibiotics
  • Anti-motility agents
  • Bismuth Subsalicylate (Pepto-Bismol)
Applications
  • Adult
  • Children
Companies covered
  • GSK
  • Sigmoid Pharma
  • Scandinavian Biopharma
  • Salix Pharmaceuticals
  • Prokarium Limited
  • Nippon Shinyaku
  • Cosmo Pharmaceuticals
  • Chiesi Farmaceutici

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Drugs for Traveler's Diarrhea Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Drugs for Traveler's Diarrhea Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Drugs for Traveler's Diarrhea Market by Type
  6. 1.3.1 Antibiotics
  7. 1.3.2 Anti-motility agents
  8. 1.3.3 Bismuth Subsalicylate (Pepto-Bismol)
  9. 1.4 Global Drugs for Traveler's Diarrhea Market Size by Type
  10. 1.4.1 Global Drugs for Traveler's Diarrhea Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Drugs for Traveler's Diarrhea Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Drugs for Traveler's Diarrhea Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Drugs for Traveler's Diarrhea Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Drugs for Traveler's Diarrhea Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Drugs for Traveler's Diarrhea Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Drugs for Traveler's Diarrhea Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Drugs for Traveler's Diarrhea Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Drugs for Traveler's Diarrhea Industry Trends
  2. 2.2 Drugs for Traveler's Diarrhea Industry Drivers
  3. 2.3 Drugs for Traveler's Diarrhea Industry Opportunities and Challenges
  4. 2.4 Drugs for Traveler's Diarrhea Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Drugs for Traveler's Diarrhea Revenue (2021-2026)
  2. 3.2 Global Top Players by Drugs for Traveler's Diarrhea Sales (2021-2026)
  3. 3.3 Global Top Players by Drugs for Traveler's Diarrhea Price (2021-2026)
  4. 3.4 Global Drugs for Traveler's Diarrhea Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drugs for Traveler's Diarrhea Major Company Production Sites & Headquarters
  6. 3.6 Global Drugs for Traveler's Diarrhea Company, Product Type & Application
  7. 3.7 Global Drugs for Traveler's Diarrhea Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drugs for Traveler's Diarrhea Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drugs for Traveler's Diarrhea Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drugs for Traveler's Diarrhea Tier 1, Tier 2, and Tier 3
4 Drugs for Traveler's Diarrhea Regional Status and Outlook
  1. 4.1 Global Drugs for Traveler's Diarrhea Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Drugs for Traveler's Diarrhea Historic Market Size by Region
  3. 4.2.1 Global Drugs for Traveler's Diarrhea Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Drugs for Traveler's Diarrhea Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Drugs for Traveler's Diarrhea Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Drugs for Traveler's Diarrhea Forecasted Market Size by Region
  7. 4.3.1 Global Drugs for Traveler's Diarrhea Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Drugs for Traveler's Diarrhea Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Drugs for Traveler's Diarrhea Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Drugs for Traveler's Diarrhea by Application
  1. 5.1 Drugs for Traveler's Diarrhea Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global Drugs for Traveler's Diarrhea Market Size by Application
  5. 5.2.1 Global Drugs for Traveler's Diarrhea Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Drugs for Traveler's Diarrhea Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Drugs for Traveler's Diarrhea Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Drugs for Traveler's Diarrhea Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Drugs for Traveler's Diarrhea Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Drugs for Traveler's Diarrhea Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Drugs for Traveler's Diarrhea Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Drugs for Traveler's Diarrhea Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Drugs for Traveler's Diarrhea Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Sigmoid Pharma
  8. 6.2.1 Sigmoid Pharma Company Information
  9. 6.2.2 Sigmoid Pharma Business Overview
  10. 6.2.3 Sigmoid Pharma Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sigmoid Pharma Drugs for Traveler's Diarrhea Product Portfolio
  12. 6.2.5 Sigmoid Pharma Recent Developments
  13. 6.3 Scandinavian Biopharma
  14. 6.3.1 Scandinavian Biopharma Company Information
  15. 6.3.2 Scandinavian Biopharma Business Overview
  16. 6.3.3 Scandinavian Biopharma Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Scandinavian Biopharma Drugs for Traveler's Diarrhea Product Portfolio
  18. 6.3.5 Scandinavian Biopharma Recent Developments
  19. 6.4 Salix Pharmaceuticals
  20. 6.4.1 Salix Pharmaceuticals Company Information
  21. 6.4.2 Salix Pharmaceuticals Business Overview
  22. 6.4.3 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio
  24. 6.4.5 Salix Pharmaceuticals Recent Developments
  25. 6.5 Prokarium Limited
  26. 6.5.1 Prokarium Limited Company Information
  27. 6.5.2 Prokarium Limited Business Overview
  28. 6.5.3 Prokarium Limited Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Prokarium Limited Drugs for Traveler's Diarrhea Product Portfolio
  30. 6.5.5 Prokarium Limited Recent Developments
  31. 6.6 Nippon Shinyaku
  32. 6.6.1 Nippon Shinyaku Company Information
  33. 6.6.2 Nippon Shinyaku Business Overview
  34. 6.6.3 Nippon Shinyaku Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Nippon Shinyaku Drugs for Traveler's Diarrhea Product Portfolio
  36. 6.6.5 Nippon Shinyaku Recent Developments
  37. 6.7 Cosmo Pharmaceuticals
  38. 6.7.1 Cosmo Pharmaceuticals Company Information
  39. 6.7.2 Cosmo Pharmaceuticals Business Overview
  40. 6.7.3 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Product Portfolio
  42. 6.7.5 Cosmo Pharmaceuticals Recent Developments
  43. 6.8 Chiesi Farmaceutici
  44. 6.8.1 Chiesi Farmaceutici Company Information
  45. 6.8.2 Chiesi Farmaceutici Business Overview
  46. 6.8.3 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Product Portfolio
  48. 6.8.5 Chiesi Farmaceutici Recent Developments
7 North America by Country
  1. 7.1 North America Drugs for Traveler's Diarrhea Sales by Country
  2. 7.1.1 North America Drugs for Traveler's Diarrhea Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Drugs for Traveler's Diarrhea Sales by Country (2021-2026)
  4. 7.1.3 North America Drugs for Traveler's Diarrhea Sales Forecast by Country (2027-2032)
  5. 7.2 North America Drugs for Traveler's Diarrhea Market Size by Country
  6. 7.2.1 North America Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Drugs for Traveler's Diarrhea Market Size by Country (2021-2026)
  8. 7.2.3 North America Drugs for Traveler's Diarrhea Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Drugs for Traveler's Diarrhea Sales by Country
  2. 8.1.1 Europe Drugs for Traveler's Diarrhea Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Drugs for Traveler's Diarrhea Sales by Country (2021-2026)
  4. 8.1.3 Europe Drugs for Traveler's Diarrhea Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Drugs for Traveler's Diarrhea Market Size by Country
  6. 8.2.1 Europe Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Drugs for Traveler's Diarrhea Market Size by Country (2021-2026)
  8. 8.2.3 Europe Drugs for Traveler's Diarrhea Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Drugs for Traveler's Diarrhea Sales by Country
  2. 9.1.1 Asia-Pacific Drugs for Traveler's Diarrhea Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Drugs for Traveler's Diarrhea Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Drugs for Traveler's Diarrhea Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Drugs for Traveler's Diarrhea Market Size by Country
  6. 9.2.1 Asia-Pacific Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Drugs for Traveler's Diarrhea Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Drugs for Traveler's Diarrhea Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Drugs for Traveler's Diarrhea Sales by Country
  2. 10.1.1 South America Drugs for Traveler's Diarrhea Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Drugs for Traveler's Diarrhea Sales by Country (2021-2026)
  4. 10.1.3 South America Drugs for Traveler's Diarrhea Sales Forecast by Country (2027-2032)
  5. 10.2 South America Drugs for Traveler's Diarrhea Market Size by Country
  6. 10.2.1 South America Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Drugs for Traveler's Diarrhea Market Size by Country (2021-2026)
  8. 10.2.3 South America Drugs for Traveler's Diarrhea Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Drugs for Traveler's Diarrhea Sales by Country
  2. 11.1.1 Middle East and Africa Drugs for Traveler's Diarrhea Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Drugs for Traveler's Diarrhea Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Drugs for Traveler's Diarrhea Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Drugs for Traveler's Diarrhea Market Size by Country
  6. 11.2.1 Middle East and Africa Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Drugs for Traveler's Diarrhea Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Drugs for Traveler's Diarrhea Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Drugs for Traveler's Diarrhea Value Chain Analysis
  2. 12.1.1 Drugs for Traveler's Diarrhea Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Drugs for Traveler's Diarrhea Production Mode & Process
  7. 12.2 Drugs for Traveler's Diarrhea Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Drugs for Traveler's Diarrhea Distributors
  10. 12.2.3 Drugs for Traveler's Diarrhea Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.